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Protems m nuclear extracts of HeLa cells that constltutlvely bound m vitro to three regions upstream of the mterferon-mduclble gene 6-16 were 
separated partially by chromatography on DEAE-Sepharose Regon one, a CCAAT box m the non-coding strand at posItIon -63 to -67, was 
protected from DNase dlgestlon by the bound protem(s) and was required for transcnption m vitro Regon two, a tandem duphcatlon sequence 
at posltlon -89 to - 168 contams two copies of a sequence ssential for strong mductlon of the 6-16 gene by Interferon m vlvo Regon three, 
a pahndrormc sequence at posItion -449 to -465, not necessary for mductlon of 6-16 by Interferon, was also protected from DNase digestion 
by nuclear protem(s) Templates with or wlthout regons of two and three were transcribed equally well m extracts from interferon-treated or un- 
treated cells 
Transcnptlon, m vitro, Interferon regulation, Transcnptlon factor 
1. INTRODUCTION 
Detailed studies of transcriptional regulation by in- 
terferons have been made possible by cloning cDNAs 
corresponding to interferon-inducible mRNAs and the 
genes themselves ([l-8]; see [9] for a recent review). 
Some of these genes are induced by any of the inter- 
ferons, whereas others are induced predominantly by 
type I (cu,,&) or type II (7) interferon. An example of the 
latter is the human gene 6-16, which is strongly induced 
by type I interferon in a variety of different cells [4,10, 
1 I]. The 6- 16 gene, which encodes a small protein of un- 
known function, is essentially silent in untreated cells. 
The mRNA accumulates transiently in the nucleus and 
steadily in the cytoplasm of interferon-treated cells 
[lo- 121, usually as a primary response insensitive to in- 
hibitors of protein synthesis uch as cycloheximide [lo]. 
We have defined regions required in vivo for induc- 
tion of 6-16 and for its basal expression by deleting 
DNA sequences upstream of the gene [ 11. This work has 
shown that a directly duplicated sequence at position 
- 89 to - 168 is responsible for most of the regulatory 
effect of interferon on the 6-16 gene. The same region 
can confer inducibility by interferon when placed up- 
stream of a heterologous marker gene. Tandemly reiter- 
ated regulatory elements are not uncommon and have 
been reported previously for heat shock, p l-interferon, 
metallothionein and glucocorticoid-regulated genes (re- 
viewed in [13]). 
Correspondence address. Yu Chernajovsky, Department of Immu- 
nology, M.D Anderson Cancer Center, 1515 Holcombe Blvd, 
Houston, TX 77030, USA 
Pubhshed by Elsevrer Scrence Pubhshers B V (Blomedrcal Dwsron) 
Transcription and protein-DNA binding experiments 
have shown that subelements of inducible enhancers 
can interact specifically with nuclear proteins in vitro. 
Sometimes the binding activities of these proteins are 
increased in response to the inducer, and sometimes 
they are not. There is an increase in the activity of pro- 
teins that bind to heat shock elements in Drosophila and 
HeLa cells in response to increased temperature [ 14,151. 
The proto-oncogene c-fos is highly induced by a variety 
of stimuli, including growth factors, cyclic AMP, calci- 
um ionophores and phorbol esters. In this case, pro- 
teins that bind to the enhancer element are found in nu- 
clear extracts from both induced and uninduced HeLa 
cells [16]. In contrast, extracts of A431 cells contain an 
activity which binds to the c-fos enhancer only when the 
cells have been treated with epidermal growth factor 
[ 171. The enhancer elements of the interferon-regulated 
mouse H-2k and fl2-microglobulin genes bmd to nu- 
clear proteins in vitro whether the cells have been 
treated with or without interferon [18]. On the other 
hand, Levy et al. [19] reported that they can detect 
interferon-modulated protein binding to the enhancer 
element of the ISG-54 gene in vitro. Similarly Porter et 
al. [l] showed interferon-specific band shifts with an 
oligonucleotide corresponding to the 3 ’ unit of the di- 
rect repeat of the 6-16 promoter, and Rutherford et al. 
[20] with a promoter fragment of the 2’-5’ oligo A syn- 
thetase gene. To further our understanding of how spe- 
cific protein-DNA interactions may regulate expression 
of the 6-16 gene, we have studied protein binding to 
three regions upstream of the mRNA start site. In no 
case was a dependence on interferon treatment ob- 
served when the whole promoter region of 6-16 was 
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used. We relate these findings to in vitro transcription 
assays and to the m vivo results of Porter et al. [l]. 
2. MATERIALS AND METHODS 
2 1 Piasmlds for m vrtro transcrlptlon assays 
The restriction sites used are shown m fig 1 The 3 2 kb XhoI- 
Asp718 (KpnI) fragment from cosmtd 10 3 [ll], contammg 2300 nu- 
cleotrdes upstream and 900 nucleotldes downstream of the start point 
of transcrtptron and mcludmg the first exon of the 6-16 gene, was 
cloned between the Sal1 and Asp718 sites of the polyhnker regton of 
plasmtd pUCl8 [21] The deleted plasmtd ABglII was obtained by 
subclonmg the 1 5 kb BglII-Asp718 fragment between the BamHI 
and Asp718 sttes of pUCl8. Thus recombinant plasmrd was then dr- 
gested with SphI, which cuts m the upstream polylinker region and 
207 nucleotrdes downstream of the Bg/II site m the 6-16 promoter, 
and then rehgated to yteld ASphI APstI was obtamed m a srmrlar 
manner wrth PstI, which cuts m the upstream polyhnker and 508 nu- 
cleotrdes downstream of the Bg/II sate 
2 2 Plasmlds for gel retardation assays 
ABglII was cleaved with HpaII and the protrudmg ends were filled 
m by use of the Klenow fragment of DNA polymerase The 0 9 kb 
HpaII fragment was Isolated, cut m the polyhnker with HmdIII and 
the resultmg fragment, contammg the sequences from - 5 to - 603, 
was cloned between the SmaI and Hind111 sttes of pUC18 to yreld 
ABglII-HpaII For gel retardation assays, erther the HmdIII or the 
Asp718 sate was labelled wtth “P and the small fragment was cut out 
wrth EC/I, which cleaves 293 nucleotrdes downstream of theBglI1 sate 
2 3 In vrtro transcnptlon assays 
Extracts were prepared as described by Dignam et al. [22] and the 
reactions were carrred out as descrrbed by these authors but using 
3 mM MgClz and 1 mM spermrdine Each plasmrd template was cut 
wtth EcoRI before use Transcrtpts were synthesized m the presence 
of unlabelled rrbonucleotrdes and the products were hybridized with 
15 pmol of the 32P-labelled pnmer 5 ‘CTTGGAGGAGAGAAGAG- 
AAG-3 ‘, whrch corresponds to the most downstream 20 nucleottdes 
of the first exon of 6-16 The primer was then extended wrth reverse 
transcrlptase [ll], the cDNA was separated m a 20% polyacrylamlde 
gel and vrsuahzed by autoradtography at - 70°C overnight with an m- 
tensrfter screen, usmg Kodak XARS film 
2 4 Gel retardatron assays 
When unfracttonated nuclear extracts were used, an amount con- 
tammg 1 pg of protein was Incubated at room temperature m 20 ~1 
with 1 pg of poly(d1 dC), 5000 cpm of labelled fragment (approx- 
imately 1 ng of DNA) m 10% glycerol, 20 mM Hepes buffer, pH 7 9, 
75 mM KC!, 0 2 mM EDTA, 0 5 mM dtthrothrertol, 0.5 mM phenyl- 
methanesulfonylfluorrde and 5 mM MgClz for 30 mm For the 
amounts of protein used m assays of fracttonated extracts, see the 
legend to ftg 4. The reaction mixtures were loaded onto 6% acryl- 
amide-bls acrylamrde gels (30.0 8) m buffer (45 mM Trrs, 45 mM 
borrc acid, 1 mM EDTA, pH 8 3) The gels were pre-run for 2 h at 
30 mA and the samples were run at 20 mA for 2-4 h, depending on 
the srze of the labelled fragment The gels were dried and autoradro- 
graphed as descrtbed above 
2 5 DNase footprmtrng 
End-labelled DNA was allowed to bmd with 10 gg of protem from 
the 0.225 M KC! fractron of the DEAE-Sepharose column m 20 pl, as 
m the retardatton assays, and 2 pl of DNase I [Worthmgton, 50 pg/ml 
stock solutron] were added The reaction mixtures were incubated for 
1 mm at room temperature and 2 ~1 of 0 25 M EDTA were added to 
stop the reactton The complexes produced m five bmdmg reactrons 
were separated from free fragments by gel electrophoresrs. The wet 
gel was autoradtographed and the retarded complexes were Isolated 
by crushmg the gel through a syrmge mto 25 ml of protemase K 
(0 2 mg/ml) in 40 mM Trts-HC!, pH 8 0,O 1 M NaCl, 20 mM EDTA 
and 0 5% SDS After shaking overnight at 37’C, the mtxture was 
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passed through srhcomzed glass wool to remove the acrylamrde par- 
ttcles and extracted twrce with phenol-chloroform (1.1) The DNA 
was concentrated by bmdmg to a column of DEAE 52-cellulose 
(0 3 ml of bed volume) and eluted wtth 1 5 M NaCl, 20 mM Trrs- 
HC!, pH 8.0, 2 mM EDTA. After preaprtatron wtth ethanol m the 
presence of 1Opg of carrier tRNA, the DNA was resuspended m 
formamide dye [1 I], denatured by boding and separated by electro- 
phoresis m a sequencing el 
2 6 Piasmlds and construction of the expressron vectors 
For subclomng purposes, we used pUCl9 [21] and for the construc- 
non of an mterferon-mducrble promoter, we cloned two ohgonu- 
cleotrdes representmg the two units of the direct repeat of the 6-16 
promoter m the polyhnker regron of the reporter plasmrd 
pBLCAT8 + [23] The cloning of the direct repeat sequence was done 
by self hgatton of the T4 kmase-treated ohgonucleotrdes correspond- 
mg to the 5 ’ and 3 ’ units of the direct repeat (fig 3), followed by re- 
strictron with TaqI which cuts the cncularrzed self-hgated ohgonu- 
cleotrde producing a complete unit of the direct repeat sequence of 
6-16 Thus fragment was cloned mto the AccI site of pUC19 Posttive 
clones were detected by hybrrdrzatron to [32P]-end-labelled ohgonu- 
cleotrdes The orrentatron of the Inserts was determmed by growing 
the Escherrchra colr DH5m bacteria m plates wrth IPTG and X-gal 
The tandem repeat m the opposite orrentatron with respect o the ,& 
galactosrdase gene produced blue colomes because rt continued the 
open readmg frame (ORF) of the enzyme. Therefore, we used a clone 
contammg the oppostte orrentation of the dtrect repeat o isolate the 
EarnHI-ZfrndIII Insert and cloned rt 5’ to the CCAAT box of the tk 
promoter m the plasmrd pBLCAT8+ The plasmrd was called 
D R pBLCAT8 + and had the tandem repeat m the same ortentatton 
as m the 6-16 nattve promoter 
In order to study the function of the CCAAT box, we removed rt 
from the D R pBLCAT8 + by tsolatmg the XbaI-BglII fragment and 
cutting It agam with HhaI which cuts at posrtron - 48, removing the 
CCAAT box We then cloned back the HhaI-BglII fragment (- 47 to 
+51) to the X&I-BglII cut plasmid using the following ohgonu- 
cleotldes 5 ‘-CTAGACTGCCTACG-3 ’ and 5 ‘-TAGGCAGT-3 ‘, 
which restores the XbaI and HhaI sates This plasmrd without a 
CCAAT box was named D.R GCCAAT 
2 7 Transient expresslon assays 
Human HeLa cells were grown m Dulbecco’s modrfted Eagle’s me- 
dium (DMEM) with 10% fetal bovme serum (FBS) The HeLa cells 
were transfected usmg DEAE dextran as the facilitator [24]. Briefly, 
two days prior to the transfectron 2 x lo6 cells were plated m 9-cm’ 
dishes The medmm was removed, and DNA at 10 pg/ml was added 
m 2 ml of DMEM wtth 250,ug/ml DEAE dextran (Pharmacra, 
Prscataway, NJ) for 1 h at 37°C Thts solutron was removed, and the 
cells were osmottcally shocked for 4 mm at room temperature wtth 
1 ml of 10% glycerol m DMEM After removal of the glycerol solu- 
tion and washmg with 10 ml of DMEM, the cells were allowed to re- 
cover for 24 to 48 h in 5 ml of DMEM with 10% FBS Then the cells 
were treated overmght with recombinant human a-interferon (Hoff- 
mann LaRoche, Nutley, NJ) at 500 U/ml 
2 8 Chloramphenrcol acetyltransferase (CAT) assays 
CAT assays were carried out as described by German et al. [25], us- 
mg 100 cg protein of cell extracts and with 0 25 &r of [i4C]chlor- 
amuhemcol at 57 mCt/mmol (Amersham) @Jo conversron was calcu- 
la&d as follows (CPM of 
acetylated chloramphenicol 
phemcol) x 100 
3. RESULTS 
acetylated chloramphemcol/CPM of 
t CPM of non-acetylated chloram- 
3.1. Structural characteristm of the 6-16 5 ‘-flanking 
region 
A partial DNA sequence and important features of 
the upstream region are shown in fig.1. There is a 
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603 -465 -449 
AGATCT GGTATGTCACATGACTA 
aolu 
-400 -310 
GCATGC T GATCAG 
sm 0d.L 
200 -190 -160 
CTGCC AGGCAGGCAG GCACACAAAT GTTCCGC 
-150 -140 -l&l -120 -110 
GGGG AAAATGAMC TCTGCAGAGT GCAGGAGCTG GGAGAGAGGG GAAAAf 
-80 -70 -60 
AAATAGA AACTCCGACA GG-T GCCTAG 
m 
-50 -40 -30 -10 
GGTG AGACGTGGGA GGATCCACAA GTGAT GCCAGCC l-fCAGC 
&!nHl 
+l +lO +20 +30 +40 
CGGA 
IjpaJ 
~AACCG I I I A CRGCTGCTG TGCCCATCTA RAGcAGGCTC CGGGC 
+50 +60 +70 
TGAAG ATTGCTTCTC TTCTCTCCTC CAAG 1 
D TATA box 0 CCAAT box 
0 Flrsl exon n SPl box 
Flg.1 The 5’-flanking region of the 6-16 gene The mam subregions 
of Interest are Indicated and are described m the text. Restriction sites 
used for subclonmg are underlined 
TATA box (ATAAAA), similar to the one upstream of 
the ,&globin gene [26], located about 20 nucleotides up- 
stream of the mRNA start site as mapped previously by 
primer extension [I 11. The sequence - 89 to - 168 con- 
tains a tandem duplication in which the upstream 41 
base pairs are repeated exactly, save for a deletion of 
two base pairs (compare position 99-100 with position 
138-141). This region is clearly very important for regu- 
lation of transcription by interferon [l]. The tandem 
duplication is preceded by a potential site for Spl site 
(GC box) at position - 167 to - 172, but there is no in- 
dication that this site plays any role in the transcrip- 
tional regulation of 6-16 [l]. There is a CCAAT box at 
- 63 to - 67 in the non-coding (minus) strand, as are 
the CCAAT boxes of the Herpes simplex virus 
thymidine kinase gene [27] and the human HSP-70 gene 
[28]. Computer analysis of the 6-16 promoter region re- 
veals several inverted repeats. One of the most stable of 
these (AG = - 11 kcal) can be represented as a structure 
in which the stem is formed by base pairing between 
nucleotides - 146 to - 134 and nucleotides - 100 to 
- 89, with most of the downstream (39 bp) unit of the 
tandem duplication in the loop formed by nucleotides 
- 133 to - 101. 
3.2. Transcrrptlon in vitro 
Soluble nuclear extracts from untreated or inter- 
feron-treated HeLa cells (freshly grown) were prepared 
as described by Dignam et al. 1221. A template that ex- 
tends from 2.3 kb upstream (XhoI) to 0.9 kb down- 
stream (KpnI) of the transcription start site [ 1 l] was ca- 
CONTROL 
BGL - 
BGL + 
AMAN - 
SPH - 
SPH + 
PST - 
PST + 
+ Hmdlll 
’ 4-(Bglll BamHl) 
4-Sphl 
4-Pstl 
4-BamHl 
+-Kpnl 
’ +EcoRl 
Fig 2 In vitro transcnption of 6-16 and effects of 5 ’ deletions m the 
5’-flankmg region. The upper panel shows the 5’-flanking region of 
6-16 schematically (not to scale). Horizontal arrows mark the posltlon 
of the Qrect repeat umts, the TATA box 1s shown in wlute and the 
black box 1s the first exon Wavy lines mdlcate the polyhnker regions 
of pUC18 The 6-16 fragment used extends from the BglII site (- 603) 
to the KpnI site (+ 900) The 5 ‘-end pomts of deletions generated by 
the use of BglII (- 603), SphI (- 397) or PstI (- 96) are mdlcated 
The posltlon of the 5 ‘-1abelled ohgodeoxynucleotlde primer used for 
reverse transcrIptIon 1s shown as an arrow The lower panel shows the 
labelled extended cDNAs, synthesized by reverse transcriptlon from 
unlabelled m vitro transcripts Large and small arrows mdlcate mqor 
and minor products, respectively Control, a transcrlptlon reaction 
run without DNA; AMAN, a transcription reactlon run with the 
BgrII template m the presence of cu-amamtm (05 pg/ml), (-), control 
extract; (+), extract from HeLa cells treated with 300 U/ml of LY- 
Interferon (Wellferon) for 4 h; markers, pBR322 digested with 
HpaII 
pable of directing correctly initiated transcription in 
vitro (data not shown). As shown in fig.2, transcription 
was initiated in vitro from a template which includes 
only 600 nucleotides of upstream sequence at the same 
position as for the endogenous gene in vivo. Deletion of 
the region between the BglII site at - 603 and the PstI 
site at - 96 caused no significant change in the level or 
site of initiation of transcription in vitro, even though 
the tandem duplication was not present (fig.2). On the 
other hand, deletion to the BamHI site at - 39 abolish- 
ed transcription completely (data not shown), showing 
that transcription is likely to be dependent on the 
CCAAT box at position - 63 to - 67. RNA polymerase 
II catalyzed the transcription in vitro since the reaction 
was inhibited by a low concentration of a-amanitin 
(fig.2). 
We tested various templates for differential tran- 
scription in extracts of interferon-treated or untreated 
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cells and found that all of them were transcribed simi- 
larly in either type of extract (fig.2). The basal level of 
transcription was not decreased when the -449 to 
-465 region or the tandem duplication were deleted. 
Active transcription of the 6-16 gene in extracts of un- 
treated cells contrasts strongly with the situation in 
vivo. We have tried in many experiments to detect dif- 
ferential regulation in vitro by using an approach simi- 
lar to that of Wildeman et al. 1291, varying the concen- 
trations of Mg*+, spermidine and DNA (50 to 500 ng). 
Still, no differential effect was seen (Chernajovsky, 
Yu,, unpublished). 
Table 1 
Regulated expresston by Interferon requires the direct repeat and 
basal expressron requues the CCAAT box 
Plasmtd Treatment % ~onverslon 
pBLCAT8 + 
D R pBLCAT8 f 
D R.GCCAAT 
none 9 79 
arIFN 44 
none 56 
rviFN 53 7 
none 03 
aIFN 03 
HeLa cells were transfected with the Indicated plasmtds and after 48 h 
the cells were extracted for CAT assay. 070 converston of the chloram- 
phemcol was assessed as explamed m sectron 2 (uIFN, cu-Interferon 
3.3. Deletion of the CCAAT box abolrshes basal and 
mducible transcriptton 
It was shown that the interaction in vitro of the direct In order to test If the direct repeat element could serve 
repeat with nuclear proteins occurs also in extracts of as a basal transcription element, we deleted a region of 
untreated cells (figs4,6). Therefore we wanted to know the promoter of the HSV tk promoter containing the 
if that interaction seen in vitro represents the binding of CCAAT box (from - 104 to -47). Table 1 shows that 
a transc~ption factor which could serve to maintain a this plasmid D.R.GCCAAT is devoid of tr~s~ription~ 
basal level of transcription. Therefore we constructed activity, both at basal level and after the cells are treated 
an interferon-inducible promoter by cloning the direct with a-interferon, showing that the CCAAT box is 
repeat element of 6-16 into the reporter plasmid essential for the basal and the inducible-enhancer activi- 
pBLCAT8+ (fig.3). The plasmid obtained named ty of the direct repeat and that the direct repeat cannot 
D.R.pBLCATS + was interferon activatable (table 1). serve as a basal transcription element. 
Frg.3. ConstNc~on of the interferon-lnduclble plasmrd D R pBLCATS+ The direct repeat of the 6-16 promoter was first cioned from two 
ohgonucleotides into pUC19 and then the BumHi-HtndIII fragment from the plasmid containmg the msert m an open readmg frame with respect 
to &galactosrdase was subcloned mto pBLCAT8 + (see sectron 2) 
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A B 
-603 -310 -310 -It -4 
CCAAT 
Fig.4. Detection and partial purification of constitutive nuclear factors that bind to the 6-16 promoter region. Transcriptionally active fractions 
from heparin-agarose columns (see the text) were chromatographed on DEAE-Sepharose columns. Increasing step concentrations of KC1 were used 
for elution, as shown by the numbers above each track (0.2 M corresponds to 0.225 M). The bars at the top of each panel indicate DNA fragments 
corresponding to different 5 ‘-flanking regions. (A) End-labelled DNA was incubated with 5 /rl of each fraction. The protein concentrations were 
determined by the procedure of Bradford [42]; they were as follows: control: hep. pool, 2 mg/ml; 0.1 M, 0.2 mg/ml; 0.225 M, 1.2 mg/ml; 0.4 M, 
0.5 mg/ml; 0.6 M, 0.1 mglml; extract, control total nuclear extract; hep. pool, pooled fraction from the heparin-agarose column; free, DNA frag- 
ment incubated with buffer alone. (B) As in panel A, but using a different DNA fragment as indicated. The hep. pool fractions had an excess of 
protein to competitor poly(dI.dC), which led to retention of the retarded complexes at the origin. The marker DNA is from pBR322, digested with 
HpaII. The different complexes resulting from protein binding to the CCAAT box and to the direct repeat (D.R.) are indicated by arrows. 
NON-CODING 
3.4. L)etection and partiul purification of nuclear 
factors that bind to the 6-16pr~~~t~r region 
We searched for nuclear proteins that could bind to 
various regions of the gene using the band-shift method 
(gel retardation assay) of Garner and Revzin [30]. The 
BamHI fragment (- 39 to + 437), which includes the 
TATA box, the first exon and part of the first intron, 
failed to form any retarded DNA-protein complex (not 
shown). Retarded complexes were detected using DNA 
Fig.5 Protection from DNase digestion of a subregion of the - 603 
to - 3 10 fragment. To obtain a labelled fragment corresponding to 
the coding strand, the restriction-cut Hind111 site of the ABg/II clone 
was labelled at the 5 ‘-end and the DNA was then cut with BclI (see 
section 2). The fragment corresponding to the non-coding strand was 
made in the same way, except hat the end-labelled DNA was cut with 
HindID. The tracks Iabelled G + A show the sequence ladders for the 
two fragments [43]. Complexes formed with the proteins eluted from 
DEAE-Sepharose in 0.225 M KCl, derived from extracts of untreated 
or interferon-treated cells, were digested with DNase I and then 
separated in a gel. They were analyzed in 6% acrylamide-urea sequen- 
cing gels. The boundaries of the protected regions are shown and the 
dyad symmetry of the protected site is indicated by arrows. 
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fragments corresponding to two different upstream 
regions of the 6-16 gene, one from BgrII to BcfI ( - 603 
to - 3 10) and a second from B&I to HpaII (- 309 to 
- 5). We fractionated the HeLa nuclear extracts 
chromatographically (fig.4A), using the first two steps 
described by Dynan and Tjian [31] for purification of 
the transcription factors Spl and CTF [32]. Extracts 
were first loaded on a heparin-agarose coIumn and the 
tr~scriptionally active fractions which were eluted in 
0.3 and 0.4 M KC1 were diluted and placed on a DEAE- 
Sepharose column at 0.1 M KCI. Proteins were eluted 
from the DEAE-Sepharose column by increasing salt 
concentration steps. Spl and CTF were eluted in 0.1 M 
KC1 [32]. The nuclear protein(s) that bound to the 
- 603 to - 310 region co-eluted in 0.225 M KCI. They 
formed a complex pattern of retarded bands (fig.4A). 
The nuclear protein(s) that bound to the -309 to -5 
region could be partially separated into two fractions 
(fig.4B). Protein(s) that formed the lower complex were 
eluted in 0.1 M and 0.225 M KCI, while protein(s) that 
formed the lower complex were eluted in 0.225 M and 
0.4 M KCl. We also observed very similar complexes 
A 
T 
C 
C 
/ 
when extracts from untreated Daudi lymphoblastoid 
cells were used (not shown). 
3.5. D~f~n~t~on of the DNA sequences that interact with 
nuclear protein(s) 
The DNase-footprinting method of Galas and 
Schmitz [33] was used, with end-labelled DNA 
fragments and protein fractions from the DEAE- 
Sepharose column. After digestion with DNase, the 
DNA-protein complexes were separated by electro- 
phoresis and extracted from the gel. Protected regions 
were detected by denaturing the DNA and analyzing it 
on sequencing gels. The nuclear protein(s) that pro- 
duced the upper and most intense complex with the 
-603 to - 310 fragment (fig.4A) protected a region 
from - 449 to - 465 which contains an almost perfect 
palindromic sequence (fig. 5). 
The upper complex, formed with the - 309 to - 5 
fragment and nuclear protein(s) that were eluted in the 
0.1 M and 0.225 M KC1 fractions of the DEAE- 
Sepharose column, showed protection of the region of 
the CCAAT box (fig.6), suggesting that the nuclear 
protein(s) involved are similar to CTF, purified by 
Jones et al. [32]. The lower complex, formed with the NON-CODING CODING 
.-%I+ 
Fig.6. Protection from DNase digestion in the upper complex formed 
with the subregion of the - 309 to - 5 subfragment. To footprint this 
region, the Asp718 site of plasmid A&$11-&?I1 (in the polylinker) 
was end-labelled with polynudeotide kinase (non-coding strand) or 
with reverse transcriptase (coding strand) and then cut with &/I. The 
upper complexes formed with this fragment and the 0.225 M KC1 
fractions from DEAE-Sephadex columns were isolated and analyzed 
as in fig.4. The tracks labelled G + A show the sequence ladders for 
each strand 1431. The boundaries of the protected regions and the cor- 
Fig.7. The lower protein-DNA complex in the - 309 to - 5 region is 
due to binding to the direct repeat region. Band shift assay using the 
- 309 to - 5 fragment (1 ng of labelled DNA) and nuclear extracts 
(1 gg of protein) of HeLa cells. Formation of the lower complex was 
competed for by increasing concen~ations of a doubIe-str~ded 
oligodeoxynucleotide corresponding to the 41 nucieotides of the 
5’-unit of the tandem duplication plus 4 nucleotides of adaptor se- 
quence. The numbers at the top of each track indicate the nanograms 
of oligodeoxynucleotide used as competitor. Arrows show the com- 
plexes formed with the CCAAT and direct repeat (D.R.) elements. 
Similar results were obtained using a synthetic oligodeoxynucleotide 
corresponding to the downstream unit of the tandem dupIicatioa 
responding DNA sequence are shown. (data not shown). 
FCCA 
D.R 
AT 
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same DNA fragment and protein(s) that were eluted in 
the 0.225 M and 0.4 M KC1 fractions, involves binding 
to the direct repeat region of the promoter, as shown by 
competition with a synthetic oligodeox~ucleotide cor- 
responding to the 41 nucleotide upstream copy of this 
repeat (fig.7). Attempts to footprint the lower complex 
with DNase were unsuccessful, even when the ex- 
periments were conducted under conditrons optimal for 
footprinting the CCAAT box. The lower complex was 
reproducibly hypersensitive to DNase and disappeared 
after digestion, even when a large excess of protein was 
used. It seems most likely that the interaction between 
the direct repeat and the nuclear protein(s) that bmds to 
it is relatively weak and that the caging effect of the 
acrylamide gel helped to stabilize the complex in the re- 
tardation assay. Indeed, in order to footprint the bind- 
ing in this region, Dale et al. [34] had to use m situ or- 
thophenantroline footprinting. 
4. DISCUSSION 
We have transcribed the interferon-inducible 6-16 
gene in vitro and have found that a CCAAT box at 
position - 63 to - 67 is required for basal expression. 
In vivo transient transfectron experiments with expres- 
sion vectors have confirmed the essential role of the 
CCAAT box. Analyses by band shifting and DNase I 
footprinting showed that nuclear protein(s) with the 
chromatographic properties of CTF [32] bound to this 
region. The exact identity of this protein(s) is not 
known since it recently has been reported by Dorn et al. 
[35] and Santoro et al. [36] that the proteins that bind 
to CCAAT boxes seem to represent a family of tran- 
scription factors with different specificities. Nuclear 
proteins are also bound to the - 448 to - 465 region 
and to the tandem duplication at position - 89 to 
- 168. The latter sequences are clearly important in 
mediating the response of the 6-16 gene to interferon 
[l]. Pine and Darnell [37] have shown that the inter- 
feron-regulatory regron of the ISG54 gene is DNase 
hypersensitive when the cells are not treated with inter- 
feron, suggesting that a nuclear factor, ISGFl, is bound 
to it. The interferon-regulatory eIement of ISG54 IS 
identical to the interferon-regulatory element of 6-16 
[l]. The constitutive complex of protein-DNA that is 
competed by the direct repeat oligonucleotide is most 
probably similar to the one formed by ISGFl. In our 
experience it has been impossible to get an inter- 
feron-modulated complex with the - 310 to - 5 pro- 
moter fragment in condrtions in which such a complex 
could be seen wrth the direct repeat ohgonucleotide [l] 
or with a cloned unit containing both units of the duect 
repeat (Chernajovsky, Yu., unpublished). This differ- 
ence is probably due to the fact that the promoter frag- 
ment is too large or because the neighboring sequences 
of the direct repeat affect bmding in vitro. Never- 
theless, deletion of both the -449 to - 465 and the 
- 89 to - 168 regions had no appreciable effect on the 
level of transcription in vitro or on the accuracy of in- 
itiation. Furthermore, transcription was as active with 
nuclear extracts from interferon-treated cells as with ex- 
tracts from untreated cells, in striking contrast to the 
situation m vlvo where the 6-16 gene 1s essentially silent 
m untreated cells. Similarly, when the early SV40 or the 
adeno major late promoter were transcribed in these ex- 
tracts, the level of transcription was similar, showing 
that the trans~riptlonal abilities of the extracts were 
equal (data not shown). There are many possibilities for 
why we did not observe correct regulation of tran- 
scription m vitro. For example, if negative regulatron IS 
important, there may not be an appreciable amount of 
free repressor protein in the nuclear extracts or the free 
DNA template may not be m an appropriate state to re- 
spond, compared with native chromatin. Alternatively, 
abnormal concentrations of transcription factors in the 
in vitro system may override control mechanisms. 
Probably the amount of the CCAAT binding protein is 
high enough to initiate transcription from the majority 
of the templates. Also, the interferon-treated extract us- 
ed was from cells treated for 4 h with interferon, a time 
at which the peak of transcription is starting to de- 
crease. Template usage is very poor in vitro; only about 
l(‘lo of the DNA is transcribed, and the rest is trapped 
m non-functions protein-DNA complexes, perhaps 
competing with active complexes for transcription fac- 
tors [31]. It is also possible that a labile post- 
translational modification of a regulatory protein, such 
as phosphorylation, may not be maintained in the nu- 
clear extracts. It may be necessary to set up a reconsti- 
tuted system in which the transcription factors can be 
added in varying amounts to distinguish among these 
and other possrbilitres. 
The binding regton at position -449 to - 465 has 
dyad symmetry and is homologous to a region found m 
the interferon-regulated mouse gene 202 ([7], and see 
fig.6 in Porter et al. [l]). The protein-DNA interaction 
in this region is unlikely to play a major role in regula- 
tion of the 6-16 gene by interferon, since the region can 
be deleted without substantial effect [l]. Perhaps the 
6-16 gene is regulated through the pahndromic -449 
tyo -465 region by stimuli other than interferon. Se- 
quences with dyad symmetry are found in regulatory 
regions of many prokaryotic and eukaryotic promoters 
and probably indicate a binding site for oligomeric pro- 
teins [l&38,39]. The sequence TGACTA within this 
region is homologous to 5 ‘-(C,G)TGACT(C,A)A-3 ‘, a 
DNA element important for regulation by transcriptron 
factor API, and because the activity which binds to this 
element increases in cells treated with phorbol esters 
[40,41], protein phosphorylation may be important in 
regulation involving DNA elements such as these. We 
are investigating the function of the -449 to -465 
region in vivo by linking it to a reporter gene. 
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Our results support the hypothesis that 6-16 1s ac- 
tivated by a yet unknown mechanism that alters the af- 
finity of ubiquitous proteins. 
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